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Introduction
Pesticide poisoning is common in Taiwan, and a sui-
cide attempt is the most common reason for pesticide
exposure.1 Oral ingestion is the most common pathway
of poisoning.1 Herbicide is a type of pesticide, and
paraquat is a widely used herbicide. Patients with para-
quat exposures have a high mortality rate in Taiwan.1
Paraquat is highly toxic to humans after oral inges-
tion. The initial clinical features of paraquat ingestion
include oral ulcer, nausea, vomiting and diarrhea. The
patient will usually die from multiorgan failure, such 
as metabolic acidosis, depression of myocardial and
respiratory function with pulmonary fibrosis, and renal
or hepatic failure. To the best of our knowledge, intra-
venous paraquat poisoning is rare,2–6 and the clinical
presentation and prognosis of such a scenario would
appear to be quite different from that of oral inges-
tion.2–6 Only 1 case of survival has been reported.4
Herein, we present a patient who attempted suicide
by means of intravenous paraquat injection.
Case Report
This 28-year-old male was an intravenous drug abuser.
He had attempted suicide several times previously,
and had received treatment for major depression. He
diluted 10 mL of 24% paraquat solution with normal
saline and injected it into a superficial vein in his left
forearm. Whilst the toxic substance was infusing, the
skin along the infused vessel developed an erythema-
tous appearance and the injection site became painful.
The patient was quickly sent to our emergency depart-
ment, approximately 2 hours post-exposure. At this
time, the patient’s consciousness was clear and he had
vital signs with a pulse of 74 beats/min, a respiratory
rate of 23 breaths/min, and blood pressure of 101/
65 mmHg. He had low body temperature (34.9°C).
The abnormal physical findings for this young man
were left arm erythema and induration. Initial complete
blood counts and biochemical data, including elec-
trolytes, liver- and renal-function tests, revealed nor-
mal results, and subsequent urinalysis did not reveal
any abnormalities. The patient’s arterial blood-gas ass-
essment displayed a PaO2 of 120 mmHg in room air.
A qualitative urine test confirmed the presence of para-
quat, and plasma paraquat concentration (6 hours
after injection) was 2.38 μg/mL.
The patient received 6 consecutive 8-hour sessions
of hemoperfusion with activated charcoal; thereafter,
urine paraquat level became negative. Intravenous
cyclophosphamide treatment (1 g) and parenteral pulse
therapy with 1 g methylprednisolone daily for 3 days
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were undertaken at the same time as hemoperfusion.
The erythematous change, pain and induration of 
the patient’s left arm progressed gradually. Some blis-
ters appeared 4 days after poisoning (Figure 1). The
patient suffered from dyspnea around 48 hours post-
exposure, and his respiratory rate was 32 breaths/min.
At this time, his arterial blood gas displayed a PaO2
value of 49.8 mmHg in room air. Follow-up chest 
X-ray revealed increasing infiltration over bilateral
lower-lung fields (Figure 2). Intubation with mechan-
ical ventilator support was then performed for acute
hypoxic respiratory failure. The patient’s dyspnea sub-
sided gradually, and the hypoxemia and chest X-ray
results (Figure 3) also appeared to reverse following
hemoperfusion and methylprednisolone pulse therapy.
Unfortunately, the patient complained of dyspnea on
the 10th day of admission. The degree of hypoxemia
(PaO2 of 51.6 mmHg) worsened. At this time, chest
X-ray revealed the presence of diffuse fibrotic changes
(Figure 4). Pulse therapy was therefore repeated with
1 g/day of methylprednisolone for 3 consecutive 
days in an attempt to suppress the inflammation. In
addition, we prescribed oral dexamethasone sub-
sequent to the pulse steroid therapy. Although he
received this aggressive management, the hypoxemia
progressed. On the 21st day subsequent to paraquat
poisoning, our patient eventually died from severe
hypoxemia.
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Figure 1. Four days following paraquat poisoning. Several vesi-
cles featuring erythematous and indurated changes have devel-
oped around the paraquat-infused vessel in the patient’s forearm.
Figure 2. Chest radiograph of the patient taken on the 3rd day of
hospitalization shows ill-defined alveolar infiltration predominant
in bilateral lower-lung fields with patch consolidation in the right
middle lobe of the lung.
Figure 4. Chest radiography taken on the 10th day of hospitaliza-
tion demonstrates diffuse fibrotic change and reticulonodular
opacities in bilateral lungs.
Figure 3. Chest radiography taken on the 5th day of hospitaliza-
tion depicts great improvement in the patient’s lungs (compared
with Figure 2).
Discussion
Paraquat (1,1-dimethyl-4,4-dipyridylium) is an effec-
tive herbicide; it is highly toxic to humans and most
animals. Unintentional and intentional oral ingestion
are the most common pathways of paraquat poisoning
in humans. According to a search of the related litera-
ture, intravenous paraquat injection is extremely rare.
MEDLINE was searched from 1966 to 2008 for cases
of intravenous paraquat poisoning in the English-
language literature. Only 6 cases were found.2–6 The
available medical data for the 6 patients and our patient
(total, 7 cases) are summarized in Table 1.
The symptoms in patients with poisoning include
local and systemic toxicological effects. The local clin-
ical presentations of intravenous paraquat poisoning
differ from those of oral poisoning. Patients with oral
paraquat ingestion suffer from oral ulcers, hemoptysis
and gastrointestinal (GI) symptoms such as nausea,
vomiting, diarrhea and GI bleeding.7 These symp-
toms are caused by direct mucosal irritation.7 Patients
with intravenous paraquat poisoning do not have
direct mucosal irritation, but they might have some
GI symptoms such as nausea and vomiting,2,5,6 which
may be explained by the systemic effect of paraquat on
the central nervous system.5 Patients with intravenous
poisoning have local skin or vessel symptoms.2,5,6 In
our patient, the injection site developed an erythema-
tous condition, and tissue swelling was initially apparent
around the site of the injected vessel. Then, several
vesicles of varying sizes appeared. Such findings have
also been reported by Hsu et al.5 The skin presentation
may be explained by local reaction due to the occur-
rence of trivial extravasation of paraquat solution to
adjacent soft tissue, and/or by local blood-vessel injury,
such as phlebitis, related specifically to paraquat injec-
tion. The systemic toxicological effects, such as renal
hepatic or pulmonary damage, come later than local
effects, and are suspected to be dose-dependent and
lethal.7 The systemic toxicological effects are also sus-
pected to have faster onset in patients with intravenous
poisoning than in patients with oral ingestion.5,6
Although there is no definitive treatment for para-
quat poisoning, patients with oral paraquat poisoning
require immediate treatment that includes: (1) pre-
venting GI absorption; (2) increasing plasma elimina-
tion; and (3) preventing pulmonary damage.7 Several
methods are suggested to prevent pulmonary dam-
age, including immunosuppressive therapy, vitamin E,
deferoxamine, and N-acetylcysteine.7 Although there
is a lack of good evidence of the clinical efficacy of
immunosuppressive therapy with glucocorticoids and
cyclophosphamide in a systematic review,8 a current
meta-analysis suspects that immunosuppressive therapy
is likely to decrease lung fibrosis and mortality.9 No
treatment protocol was suggested for patients of intra-
venous paraquat poisoning. Because of the limited
number of cases (Table 1), there are no existing treat-
ment protocols to improve the grave outcome for
patients with paraquat injection.
Proudfoot et al were the first to suggest that
paraquat concentration-time ratio before treatment
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Table 1. Summary of clinical manifestations and outcomes of patients with intravenous paraquat poisoning
Plasma paraquat Predictive 
Patients
Age
Sex concentration (μg/mL) survival Management Outcome
(yr)
(hours after injection) rate (%)*




Hendy et al3 42 M 2.3 (4) 30–50 Hemoperfusion × 2 Survived
Fernandez et al4 21 M 0.62 (6) 50–70 Hemoperfusion + propranolol Died after 15 d
Hsu et al5 35 F 18 (5) < 10 Hemoperfusion × 2 + Died after 4 d
cyclophosphamide +
pulse therapy
Hsu et al5 37 M 19.6 (1) < 10 Hemoperfusion × 2 + Died after 5 d
cyclophosphamide +
pulse therapy
Choi et al6 31 F 21 (10) < 10 Hemoperfusion × 2 Died after 3 d
Present case 28 M 2.38 (6) 20–30 Hemoperfusion × 6 + Died after 21 d
cyclophosphamide +
repeated pulse therapy
*According to the formula of Hart et al.12
could predict the outcome of poisoning.10 Several
prediction methods were developed. Five methods were
compared in a large cohort study, and these methods
are likely to be accurate in predicting death for
patients with paraquat poisoning.11 Hart et al created
a nomogram with 6 concentration-time curves of
about 10–90% survival probability,12 and the nomo-
gram is easy to use in the emergency department.
Sawada et al presented a severity index of paraquat
poisoning (SIPP) which was calculated according to
the serum level of paraquat,13 and the serum concen-
trations were lower than plasma concentration.7 We
could not calculate the SIPP because we only have the
plasma paraquat concentrations of the 6 patients with
intravenous paraquat from published reports. Jones
developed an equation to predict the probability of
survival for any specific time,14 but it is too complex
to be of practical use in the emergency department.
Because paraquat enters the body more rapidly by
intravenous injection than by oral exposure, the prog-
nosis of intravenous paraquat poisoning might be
worse than that of oral poisoning. We tried to predict
the mortality rate of the 6 patients with intravenous
paraquat according to the formula of Hart et al,12 and
5 of the 6 patients were considered to have a very
high mortality rate (Table 1).2–6 Six of the 7 patients
(including the present case) did not survive after
aggressive treatment (Table 1).2–6 Only 1 miraculous
case survived from severe pulmonary damage due to
paraquat administered intravenously and orally.2 The
predictive mortality method according to the formula
of Hart et al12 seems to be suitable for use with cases of
intravenous paraquat. However, as there is an inade-
quate number of cases who survived, we cannot test the
survival prediction ability of Hart et al’s nomogram.
In conclusion, intravenous paraquat poisoning is
rare, and patients may manifest with a variety of symp-
toms including initial dermal changes. These symptoms
often appear immediately subsequent to paraquat
injection. The prognosis of intravenous paraquat poi-
soning is graver than that of oral poisoning. Further
experimental and clinical trials are required to search
for an effective treatment for patients suffering from
intravenous paraquat poisoning.
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